ArticleFrontiers in pediatrics2025
Endoluminal functional lumen imaging probe: a new modality in the evaluation of esophageal disorders in children and preliminary use in eosinophilic esophagitis.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Evaluating pediatric esophageal motility and structural disorders such as eosinophilic esophagitis (EoE) remains challenging. Conventional modalities are limited in their ability to assess biomechanical properties of the gastrointestinal tract, such as luminal compliance and distensibility. The endoluminal functional lumen imaging probe (FLIP) is a minimally invasive technology that uses impedance planimetry to measure esophageal parameters. Recent studies have shown the utility of FLIP in quantifying esophageal remodeling and fibrostenotic severity. FLIP-derived esophageal distensibility index (DI) is a sensitive marker for subclinical fibrosis and rigidity, often identifying esophageal narrowing not apparent on endoscopy or by symptom assessment alone. We investigated the use of FLIP to capture early esophageal dysfunction in patients with EoE, especially those in clinical remission. Methods: Retrospective chart review of patients with EoE who underwent EndoFLIP at our institution. EndoFLIP 2.0 Impedance Planimetry System was used via standard protocol. Variables in patients with EoE were compared by unpaired t-test. Results: Ten patients fulfilled inclusion criteria and 70% of the cohort were in clinical remission. The average minimum diameter at the narrowest luminal point at the maximum fill volume was 11.3 mm ± 3.3. The average distensibility index was 3.1 mm Discussion: EndoFLIP was able to detect esophageal dysfunction in pediatric patients with EoE as evidenced by an overall low distensibility index. This adjunctive tool appears particularly useful in asymptomatic patients with EoE in clinical and histologic remission, as it may detect residual esophageal dysfunction highlighting the importance of early detection and ongoing therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.